Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
03/02/2020	13h30	PR Newswire (US)	Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchie...	NASDAQ:INSM	Insmed Inc
30/01/2020	14h00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INSM	Insmed Inc
30/01/2020	14h00	PR Newswire (US)	Insmed Appoints Sara Bonstein as Chief Financial Officer	NASDAQ:INSM	Insmed Inc
09/01/2020	14h00	PR Newswire (US)	Insmed to Present at the 38th Annual J.P. Morgan Healthcare Conference	NASDAQ:INSM	Insmed Inc
08/01/2020	00h14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INSM	Insmed Inc
03/01/2020	22h05	PR Newswire (US)	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:INSM	Insmed Inc
18/12/2019	22h06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INSM	Insmed Inc
26/11/2019	14h00	PR Newswire (US)	Insmed to Present at Two December Conferences	NASDAQ:INSM	Insmed Inc
20/11/2019	22h09	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	NASDAQ:INSM	Insmed Inc
14/11/2019	14h00	PR Newswire (US)	Insmed Appoints Dr. Clarissa Desjardins to its Board of Directors and Names Roger Adsett Chief Operating Officer	NASDAQ:INSM	Insmed Inc
05/11/2019	14h00	PR Newswire (US)	Insmed to Present at Two November Conferences	NASDAQ:INSM	Insmed Inc
30/10/2019	12h32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INSM	Insmed Inc
30/10/2019	12h30	PR Newswire (US)	Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
23/10/2019	14h00	PR Newswire (US)	Insmed to Host Third Quarter 2019 Financial Results Conference Call on Wednesday, October 30, 2019	NASDAQ:INSM	Insmed Inc
03/09/2019	14h00	PR Newswire (US)	Insmed to Present at Two September Conferences	NASDAQ:INSM	Insmed Inc
22/08/2019	22h12	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:INSM	Insmed Inc
01/08/2019	13h30	PR Newswire (US)	Insmed Reports Second Quarter 2019 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
25/07/2019	14h00	PR Newswire (US)	Insmed to Host Second Quarter 2019 Financial Results Conference Call on Thursday, August 1, 2019	NASDAQ:INSM	Insmed Inc
26/06/2019	22h50	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:INSM	Insmed Inc
26/06/2019	22h41	PR Newswire (US)	Insmed Announces Closing of Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
06/06/2019	14h00	PR Newswire (US)	Insmed to Present at the Goldman Sachs 40th Annual Global Healthcare Conference	NASDAQ:INSM	Insmed Inc
23/05/2019	12h04	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INSM	Insmed Inc
22/05/2019	12h03	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	NASDAQ:INSM	Insmed Inc
22/05/2019	02h56	PR Newswire (US)	Insmed Announces Pricing of Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
20/05/2019	22h05	PR Newswire (US)	Insmed Announces Proposed Public Offering of Common Stock	NASDAQ:INSM	Insmed Inc
20/05/2019	22h01	PR Newswire (US)	New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspe...	NASDAQ:INSM	Insmed Inc
07/05/2019	13h30	PR Newswire (US)	Insmed Reports First Quarter 2019 Financial Results and Provides Business Update	NASDAQ:INSM	Insmed Inc
30/04/2019	14h00	PR Newswire (US)	Insmed to Host First Quarter 2019 Financial Results Conference Call on Tuesday, May 7, 2019	NASDAQ:INSM	Insmed Inc
09/04/2019	22h36	PR Newswire (US)	Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global ...	NASDAQ:INSM	Insmed Inc
08/04/2019	11h00	PR Newswire (US)	Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch	NASDAQ:INSM	Insmed Inc